{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:59Z","timestamp":1790223419713,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00428-017-2107-1","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T08:41:06Z","timestamp":1489999266000},"page":"575-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease"],"prefix":"10.1007","volume":"470","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1025-7171","authenticated-orcid":false,"given":"Alessandro","family":"Pileri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tomasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vieri","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Astrua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Patrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pimpinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"2107_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1053\/j.semdp.2011.04.002","volume":"28","author":"A Pileri Jr","year":"2011","unstructured":"Pileri A Jr, Patrizi A, Agostinelli C et al (2011) Primary cutaneous lymphomas: a reprisal. Semin Diagn Pathol 28:214\u2013233","journal-title":"Semin Diagn Pathol"},{"key":"2107_CR2","first-page":"523","volume":"147","author":"P Quaglino","year":"2012","unstructured":"Quaglino P, Pimpinelli N, Berti E et al (2012) Mycosis fungoides: disease evolution of the \u201clion queen\u201d revisited. G Ital Dermatol Venereol 147:523\u2013531","journal-title":"G Ital Dermatol Venereol"},{"key":"2107_CR3","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","volume":"33","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ, Prince HM, Vermeer MH et al (2015) Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol 33:3766\u20133773","journal-title":"J Clin Oncol"},{"key":"2107_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","volume":"53","author":"N Pimpinelli","year":"2005","unstructured":"Pimpinelli N, Olsen EA, Santucci M et al (2005) Defining early mycosis fungoides. J Am Acad Dermatol 53:1053\u20131063","journal-title":"J Am Acad Dermatol"},{"key":"2107_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jcp.2005.033019","volume":"59","author":"L Cerroni","year":"2006","unstructured":"Cerroni L (2006) Lymphoproliferative lesions of the skin. J Clin Pathol 59:813\u2013826","journal-title":"J Clin Pathol"},{"key":"2107_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2141.2011.08852.x","volume":"155","author":"HK Wong","year":"2011","unstructured":"Wong HK, Mishra A, Hake T et al (2011) Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol 155:150\u2013166","journal-title":"Br J Haematol"},{"key":"2107_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ajh.24233","volume":"91","author":"RA Wilcox","year":"2016","unstructured":"Wilcox RA (2016) Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91:151\u2013165","journal-title":"Am J Hematol"},{"key":"2107_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD (2004a) The three Es of cancer immunoediting. Annu Rev Immunol 22:329\u2013360","journal-title":"Annu Rev Immunol"},{"key":"2107_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991\u2013998","journal-title":"Nat Immunol"},{"key":"2107_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD (2004b) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137\u2013148","journal-title":"Immunity"},{"key":"2107_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/86297","volume":"2","author":"MJ Smyth","year":"2001","unstructured":"Smyth MJ, Godfrey DI, Trapani JA (2001) A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2:293\u2013299","journal-title":"Nat Immunol"},{"key":"2107_CR12","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","volume":"105","author":"CL Berger","year":"2005","unstructured":"Berger CL, Tigelaar R, Cohen J et al (2005) Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105:1640\u20131647","journal-title":"Blood"},{"key":"2107_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/DAD.0b013e31823062db","volume":"34","author":"I Fried","year":"2012","unstructured":"Fried I, Cerroni L (2012) FOXP3 in sequential biopsies of progressive mycosis fungoides. Am J Dermatopathol 34:263\u2013265","journal-title":"Am J Dermatopathol"},{"key":"2107_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2133.1976.tb04374.x","volume":"94","author":"M Goos","year":"1976","unstructured":"Goos M, Kaiserling E, Lennert K (1976) Mycosis fungoides: model for T-lymphocyte homing to the skin? Br J Dermatol 94:221\u2013222","journal-title":"Br J Dermatol"},{"key":"2107_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0733-8635(18)30173-6","volume":"12","author":"N Pimpinelli","year":"1994","unstructured":"Pimpinelli N, Santucci M, Romagnoli P et al (1994) Dendritic cells in T- and B-cell proliferation in the skin. Dermatol Clin 12:255\u2013270","journal-title":"Dermatol Clin"},{"key":"2107_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1365-2133.2002.04994.x","volume":"147","author":"M L\u00fcftl","year":"2002","unstructured":"L\u00fcftl M, Feng A, Licha E et al (2002) Dendritic cells and apoptosis in mycosis fungoides. Br J Dermatol 147:1171\u20131179","journal-title":"Br J Dermatol"},{"key":"2107_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1468-3083.2010.03882.x","volume":"25","author":"M Der-Petrossian","year":"2011","unstructured":"Der-Petrossian M, Valencak J, Jonak C et al (2011) Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin+ dendritic cells. J Eur Acad Dermatol Venereol 25:922\u2013927","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2107_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jaad.2009.06.082","volume":"62","author":"C Schlapbach","year":"2010","unstructured":"Schlapbach C, Ochsenbein A, Kaelin U et al (2010) High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma. J Am Acad Dermatol 62:995\u20131004","journal-title":"J Am Acad Dermatol"},{"key":"2107_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2340\/00015555-1220","volume":"92","author":"P Schwingshackl","year":"2012","unstructured":"Schwingshackl P, Obermoser G, Nguyen VA et al (2012) Distribution and maturation of skin dendritic cell subsets in two forms of cutaneous T-cell lymphoma: mycosis fungoides and S\u00e9zary syndrome. Acta Derm Venereol 92:269\u2013275","journal-title":"Acta Derm Venereol"},{"key":"2107_CR20","first-page":"553","volume":"18","author":"QA Zhang","year":"2014","unstructured":"Zhang QA, Chen ZQ, Chen MH et al (2014) The number of regular T cells and immature dendritic cells involved in mycosis fungoides is linked to the tumor stage. Eur Rev Med Pharmacol Sci 18:553\u2013558","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2107_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 9:162\u2013174","journal-title":"Nat Rev Immunol."},{"key":"2107_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E et al (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37:208\u2013220","journal-title":"Trends Immunol"},{"key":"2107_CR23","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1002\/eji.201040895","volume":"40","author":"JI Youn","year":"2010","unstructured":"Youn JI, Gabrilovich DI (2010) The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40:2969\u20132975","journal-title":"Eur J Immunol"},{"key":"2107_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1668","volume":"5","author":"V Bronte","year":"2005","unstructured":"Bronte V, Zanovello P (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5:641\u2013654","journal-title":"Nat Rev Immunol"},{"key":"2107_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","volume":"222","author":"PC Rodr\u00edguez","year":"2008","unstructured":"Rodr\u00edguez PC, Ochoa AC (2008) Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 222:180\u2013191","journal-title":"Immunol Rev"},{"key":"2107_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ccell.2015.07.006","volume":"28","author":"L Strauss","year":"2015","unstructured":"Strauss L, Sangaletti S, Consonni FM et al (2015) RORC1 regulates tumor-promoting \u201cemergency\u201d granulo-monocytopoiesis. Cancer Cell 28:253\u2013269","journal-title":"Cancer Cell"},{"key":"2107_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1084\/jem.20050715","volume":"202","author":"PC Rodriguez","year":"2005","unstructured":"Rodriguez PC, Hernandez CP, Quiceno D et al (2005) Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med 202:931\u2013939","journal-title":"J Exp Med"},{"key":"2107_CR28","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","volume":"68","author":"P Serafini","year":"2008","unstructured":"Serafini P, Mgebroff S, Noonan K et al (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 68:5439\u20135449","journal-title":"Cancer Res"},{"key":"2107_CR29","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","volume":"66","author":"B Huang","year":"2006","unstructured":"Huang B, Pan PY, Li Q et al (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66:1123\u20131131","journal-title":"Cancer Res"},{"key":"2107_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","volume":"70","author":"PY Pan","year":"2010","unstructured":"Pan PY, Ma G, Weber KJ et al (2010) Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 70:99\u2013108","journal-title":"Cancer Res"},{"key":"2107_CR31","doi-asserted-by":"publisher","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","volume":"67","author":"SK Bunt","year":"2007","unstructured":"Bunt SK, Yang L, Sinha P et al (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67:10019\u201310026","journal-title":"Cancer Res"},{"key":"2107_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK, Sinha P, Clements VK et al (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70:68\u201377","journal-title":"Cancer Res"},{"issue":"183","key":"2107_CR33","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4049\/jimmunol.0804253","volume":"15","author":"EM Hanson","year":"2009","unstructured":"Hanson EM, Clements VK, Sinha P et al (2009) Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J Immunol 15(183):937\u2013944","journal-title":"J Immunol"},{"key":"2107_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3324\/haematol.2015.132761","volume":"101","author":"S Vardhana","year":"2016","unstructured":"Vardhana S, Younes A (2016) The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints. Haematologica 101:794\u2013802","journal-title":"Haematologica"},{"key":"2107_CR35","volume":"4","author":"AA Wu","year":"2015","unstructured":"Wu AA, Drake V, Huang HS et al (2015) Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. Oncoimmunology 4:e1016700","journal-title":"Oncoimmunology"},{"key":"2107_CR36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1214\/aos\/1013699990","volume":"29","author":"H Dette","year":"2001","unstructured":"Dette H, Neumeyer N (2001) Nonparametric analysis of covariance. Ann Stat 29:1361\u20131400","journal-title":"Ann Stat"},{"key":"2107_CR37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2307\/2532993","volume":"51","author":"SG Young","year":"1995","unstructured":"Young SG, Bowman AW (1995) Non-parametric analysis of covariance. Biometrics 51:920\u2013931","journal-title":"Biometrics"},{"key":"2107_CR38","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.jspi.2010.03.011","volume":"140","author":"XF Wang","year":"2010","unstructured":"Wang XF, Ye D (2010) On nonparametric comparison of images and regression surfaces. J Stat Plann Inference 140:2875\u20132884","journal-title":"J Stat Plann Inference"},{"key":"2107_CR39","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","volume":"92","author":"D Gabrilovich","year":"1998","unstructured":"Gabrilovich D, Ishida T, Oyama T et al (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92:4150\u20134166","journal-title":"Blood"},{"key":"2107_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/his.12445","volume":"66","author":"A Pileri","year":"2015","unstructured":"Pileri A, Agostinelli C, Righi S et al (2015) Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides. Histopathology 66:173\u2013181","journal-title":"Histopathology"},{"key":"2107_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1182\/blood-2011-05-355222","volume":"119","author":"YH Kim","year":"2012","unstructured":"Kim YH, Gratzinger D, Harrison C et al (2012) In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1\/2 study. Blood 119:355\u2013363","journal-title":"Blood"},{"key":"2107_CR42","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1172\/JCI41936","volume":"121","author":"LA Mauti","year":"2011","unstructured":"Mauti LA, Le Bitoux MA, Baumer K et al (2011) Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J Clin Invest 121:2794\u20132807","journal-title":"J Clin Invest"},{"key":"2107_CR43","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1038\/jid.2015.241","volume":"135","author":"DG Mairhofer","year":"2015","unstructured":"Mairhofer DG, Ortner D, Tripp CH et al (2015) Impaired gp100-specific CD8(+) T-cell responses in the presence of myeloid-derived suppressor cells in a spontaneous mouse melanoma model. J Invest Dermatol 135:2785\u20132793","journal-title":"J Invest Dermatol"},{"key":"2107_CR44","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.3324\/haematol.2015.132837","volume":"100","author":"C P\u00e9rez","year":"2015","unstructured":"P\u00e9rez C, Gonz\u00e1lez-Rinc\u00f3n J, Onaindia A et al (2015) Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma. Haematologica 100:e450\u2013e453","journal-title":"Haematologica"},{"key":"2107_CR45","doi-asserted-by":"publisher","unstructured":"Dufait I, Van Valckenborgh E, Menu E, et al. (2016) Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy. Oncotarget. [Epub ahead of print].","DOI":"10.18632\/oncotarget.8311"},{"key":"2107_CR46","doi-asserted-by":"crossref","unstructured":"Fava P, Bergallo M, Astrua C, et al. (2016) miR-155 expression in primary cutaneous T- cell lymphomas (CTCL). J Eur Acad Dermatol Venereol. [Epub ahead of print].","DOI":"10.1111\/jdv.13597"},{"key":"2107_CR47","volume":"2","author":"S Chen","year":"2015","unstructured":"Chen S, Zhang Y, Kuzel TM et al (2015) Regulating tumor myeloid-derived suppressor cells by microRNAs. Cancer Cell Microenviron 2:e637","journal-title":"Cancer Cell Microenviron"},{"key":"2107_CR48","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.18632\/oncotarget.7150","volume":"7","author":"S Kim","year":"2016","unstructured":"Kim S, Song JH, Kim S et al (2016) Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C\/EBP-\u03b2-mediated MDSC infiltration. Oncotarget 7:11094\u201311112","journal-title":"Oncotarget"},{"key":"2107_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biomaterials.2016.04.010","volume":"96","author":"MS Sasso","year":"2016","unstructured":"Sasso MS, Lollo G, Pitorre M et al (2016) Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy. Biomaterials 96:47\u201362","journal-title":"Biomaterials"},{"key":"2107_CR50","doi-asserted-by":"publisher","first-page":"24506","DOI":"10.1038\/srep24506","volume":"6","author":"W He","year":"2016","unstructured":"He W, Liang P, Guo G et al (2016) Re-polarizing myeloid-derived suppressor cells (MDSCs) with cationic polymers for cancer immunotherapy. Sci Rep 6:24506","journal-title":"Sci Rep"},{"key":"2107_CR51","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell JJ, Clark RA, Watanabe R et al (2010) Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 116:767\u2013771","journal-title":"Blood"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2107-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-017-2107-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2107-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T03:54:30Z","timestamp":1601783670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-017-2107-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1007\/s00428-017-2107-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}